Global PVQ SE
Q-Cells SE: The revocation of admission to trading on the regulated market to section 39 (2) of the German Stock Exchange Act in conjunction with section 46 (1) of the Exchange Rules of the Frankfurt Stock Exchange shall take effect after 12 March 2013

Q-Cells SE  / Key word(s): Delisting

12.09.2012 20:00

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Bitterfeld-Wolfen (Germany), 12 September 2012: The Frankfurt Stock
Exchange announced today that the application submitted by the
administrator in the insolvency proceedings regarding the assets of Q-Cells
SE, Mr Henning Schorisch (lawyer), for the revocation of admission to
trading on the regulated market (General Standard) pursuant to section 39
(2) of the German Stock Exchange Act (Börsengesetz) in conjunction with
section 46 (1) of the Exchange Rules (Börsenordnung) in respect of the
shares in Q-Cells SE was accepted and that the revocation shall take effect
after 12 March 2013.

Thus, with the expiry of 12 March 2013, the last remaining admission of the
company's shares to trading on a regulated market also ends.

CONTACT

Q-Cells SE i.I.
OT Thalheim, Sonnenallee 17-21
06766 Bitterfeld-Wolfen, Germany
FAX +49 (0)3494 6699.10000
WEB www.q-cells.de

Q.CELLS Investor Relations
Stefan Lissner
TEL +49 (0)3494 6699.10101
EMAIL investor@q-cells.com

Q.CELLS Corporate Communications
Ina von Spies, Alberta Rohardt
TEL +49 (0)3494 6699.10121
EMAIL presse@q-cells.com

Lawyer Henning Schorisch as insolvency administrator of Q-Cells SE
Executive Board: Dr Nedim Cen (CEO, CFO), Dr Andreas v. Zitzewitz (COO,
CSO)
Chairman of the Supervisory Board: Prof Dr h c Karlheinz Hornung


12.09.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      Q-Cells SE
              Sonnenallee 17-21, OT Thalheim
              06766 Bitterfeld-Wolfen
              Germany
Phone:        +49 (0)3494 - 6699-0
Fax:          +49 (0)3494 - 6699-199
E-mail:       q-cells@q-cells.com
Internet:     www.q-cells.com
ISIN:         DE0005558662, Wandelanleihe 2012: DE000A0LMY64, Wandelanleihe
              2014: DE000A1AGZ06, Wandelanleihe 2015: DE000A1E8HF6
WKN:          555866
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------